- Home
- LNTH vs VNO Comparison
LNTH vs VNO Comparison
Compare LNTH & VNO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LNTH
- VNO
- Stock Information
- Founded
- LNTH 1956
- VNO 1946
- Country
- LNTH United States
- VNO United States
- Employees
- LNTH N/A
- VNO N/A
- Industry
- LNTH Biotechnology: In Vitro & In Vivo Diagnostic Substances
- VNO Real Estate Investment Trusts
- Sector
- LNTH Health Care
- VNO Real Estate
- Exchange
- LNTH Nasdaq
- VNO Nasdaq
- Market Cap
- LNTH 7.5B
- VNO 7.0B
- IPO Year
- LNTH 2015
- VNO N/A
- Fundamental
- Price
- LNTH $79.78
- VNO $39.46
- Analyst Decision
- LNTH Strong Buy
- VNO Hold
- Analyst Count
- LNTH 5
- VNO 11
- Target Price
- LNTH $133.80
- VNO $38.00
- AVG Volume (30 Days)
- LNTH 1.4M
- VNO 1.3M
- Earning Date
- LNTH 05-07-2025
- VNO 05-05-2025
- Dividend Yield
- LNTH N/A
- VNO 1.90%
- EPS Growth
- LNTH N/A
- VNO 248.25
- EPS
- LNTH 3.53
- VNO 0.52
- Revenue
- LNTH $1,536,699,000.00
- VNO $1,929,890,000.00
- Revenue This Year
- LNTH $4.96
- VNO N/A
- Revenue Next Year
- LNTH $10.25
- VNO $5.12
- P/E Ratio
- LNTH $22.59
- VNO $74.18
- Revenue Growth
- LNTH 12.53
- VNO 2.98
- 52 Week Low
- LNTH $74.34
- VNO $22.42
- 52 Week High
- LNTH $126.89
- VNO $46.63
- Technical
- Relative Strength Index (RSI)
- LNTH 29.82
- VNO 61.24
- Support Level
- LNTH $77.01
- VNO $38.63
- Resistance Level
- LNTH $83.60
- VNO $40.73
- Average True Range (ATR)
- LNTH 3.74
- VNO 1.20
- MACD
- LNTH -2.67
- VNO 0.40
- Stochastic Oscillator
- LNTH 8.68
- VNO 81.81
About LNTH Lantheus Holdings Inc.
Lantheus Holdings Inc caters to the United States healthcare sector with the development of diagnostic products. Its products are in three categories: Precision Diagnostics, Radiopharmaceutical Oncology, and Strategic Partnerships and Other Revenue. Precision Diagnostic products assist healthcare professionals Find and Follow diseases, with a focus in cardiology. Radiopharmaceutical Oncology diagnostics and therapeutics help HCPs Find, Fight and Follow cancer. Strategic Partnerships focus on enabling precision medicine through the use of biomarkers, digital solutions and pharma services platforms, and also includes license of RELISTOR to Bausch Health Companies, Inc.
About VNO Vornado Realty Trust
Vornado owns and has an ownership interest in Class A office and retail properties highly concentrated in Manhattan, with additional properties in San Francisco and Chicago. It operates as a real estate investment trust.